COMT Variant rs4818 May Be Associated With Reduced CVD Risk And Lower Fibrinogen Levels, But Not Subclinical Atherosclerosis, Research Suggests

Cardiology Advisor (2/3, Rothbard) reports, “The catechol-O-methyltransferase (COMT) variant rs4818 may be associated with a reduced risk for cardiovascular disease (CVD) and lower fibrinogen levels, but not subclinical atherosclerosis,” investigators con...